Ultimum HEMOSTASIS INTRODUCER 5f 1.67 MM

FDA Device Recall #Z-0420-2022 — Class II — November 16, 2021

Recall Summary

Recall Number Z-0420-2022
Classification Class II — Moderate risk
Date Initiated November 16, 2021
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Abbott
Location Plymouth, MN
Product Type Devices
Quantity 10 units

Product Description

Ultimum HEMOSTASIS INTRODUCER 5f 1.67 MM

Reason for Recall

As a result of a manufacturing error, one (1) lot of Ultimum Hemostasis Introducer devices was manufactured with an incorrect hub and overall length. The devices manufactured were 12 cm in length instead of the intended 5 cm in length.

Distribution Pattern

Worldwide distribution - US Nationwide distribution in the state of Missouri and the country of Australia.

Lot / Code Information

Model 407831, Lot 7748246, GTIN: 15414734008805

Other Recalls from Abbott

Recall # Classification Product Date
Z-0111-2026 Class I TactiFlex Sensor Enabled Ablation Catheter, 8F,... Sep 10, 2025
Z-0109-2026 Class I TactiFlex Sensor Enabled Ablation Catheter, 8F,... Sep 10, 2025
Z-0112-2026 Class I TactiFlex Sensor Enabled Ablation Catheter, 8F,... Sep 10, 2025
Z-0110-2026 Class I TactiFlex Sensor Enabled Ablation Catheter, 8F,... Sep 10, 2025
Z-0113-2026 Class I TactiFlex Sensor Enabled Ablation Catheter, 8F,... Sep 10, 2025

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.